We are live on ! Find out more
CA

Claris Advisors Portfolio holdings

AUM $383M
1-Year Est. Return 27.62%
This Fund
S&P 500
This Quarter Est. Return
-1.46%
1 Year Est. Return
+27.62%
3 Year Est. Return
+65.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$35.3M
Cap. Flow
+$40M
Cap. Flow %
15.04%
Top 10 Hldgs %
75.67%
Holding
1,237
New
2
Increased
60
Reduced
8
Closed
1,166

Top Buys

Rank Stock Value
1
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$13.5M
2
BSVO icon
EA Bridgeway Omni Small-Cap Value ETF
BSVO
+$5.18M
3
DFAX icon
Dimensional World ex US Core Equity 2 ETF
DFAX
+$5.03M
4
DUHP icon
Dimensional US High Profitability ETF
DUHP
+$4.65M
5
DISV icon
Dimensional International Small Cap Value ETF
DISV
+$3.32M

Top Sells

Rank Stock Value
1
DFAR icon
Dimensional US Real Estate ETF
DFAR
+$204K
2
SCZ icon
iShares MSCI EAFE Small-Cap ETF
SCZ
+$195K
3
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$190K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$188K
5
GD icon
General Dynamics
GD
+$181K

Sector Composition

Rank Sector Weight
1 Technology 2.78%
2 Financials 1.8%
3 Industrials 1.26%
4 Consumer Discretionary 0.99%
5 Healthcare 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDC icon
1026
Teradata
TDC
$2.8B
– –
-4
Closed -$121
TDOC icon
1027
Teladoc Health
TDOC
$1.61B
– –
-5
Closed -$46
TDS icon
1028
Telephone and Data Systems
TDS
$3.83B
– –
-1
Closed -$23
TDY icon
1029
Teledyne Technologies
TDY
$30.2B
– –
-2
Closed -$875
TECH icon
1030
Bio-Techne
TECH
$11.2B
– –
-5
Closed -$400
TER icon
1031
Teradyne
TER
$52.4B
– –
-5
Closed -$670
TEVA icon
1032
Teva Pharmaceuticals
TEVA
$36.2B
– –
-1,097
Closed -$19.8K
TEX icon
1033
Terex
TEX
$7.89B
– –
-5
Closed -$265
TFC icon
1034
Truist Financial
TFC
$63.7B
– –
-16
Closed -$684
TFIN icon
1035
Triumph Financial Inc
TFIN
$1.8B
– –
-1
Closed -$80
TFSL icon
1036
TFS Financial
TFSL
$5.07B
– –
-9
Closed -$116
TFX icon
1037
Teleflex
TFX
$5.8B
– –
-2
Closed -$495
TGLS icon
1038
Tecnoglass
TGLS
$2.01B
– –
-1
Closed -$69
TGT icon
1039
Target
TGT
$63.7B
– –
-811
Closed -$126K
TGTX icon
1040
TG Therapeutics
TGTX
$8.53B
– –
-425
Closed -$9.94K
THC icon
1041
Tenet Healthcare
THC
$21B
– –
-6
Closed -$997
THO icon
1042
Thor Industries
THO
$3.98B
– –
-4
Closed -$440
THRM icon
1043
Gentherm
THRM
$1.29B
– –
-2
Closed -$93
TIP icon
1044
iShares TIPS Bond ETF
TIP
$14.5B
– –
-235
Closed -$26K
TJX icon
1045
TJX Companies
TJX
$173B
– –
-48
Closed -$5.64K
TKR icon
1046
Timken Company
TKR
$9.81B
– –
-5
Closed -$421
TKO icon
1047
TKO Group
TKO
$13.7B
– –
-2
Closed -$247
TMHC icon
1048
Taylor Morrison
TMHC
– –
-10
Closed -$703
TMO icon
1049
Thermo Fisher Scientific
TMO
$208B
– –
-20
Closed -$12.4K
TMUS icon
1050
T-Mobile US
TMUS
$190B
– –
-32
Closed -$6.6K
40 41
42
43 44

Similar funds

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
RC
RV Capital Schindellegi, Switzerland $383M AUM 21.52% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $383M AUM 17.99% 1-Year Est. Return
LWM
Luminvest Wealth Management Scottsdale, Arizona $382M AUM 14.3% 1-Year Est. Return
RSS
Rosenblum Silverman Sutton San Francisco, California $382M AUM 13.82% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
STP
Science & Technology Partners New York $382M AUM 202.26% 1-Year Est. Return

Claris Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Claris Advisors held 1,237 positions worth $266M, up 15% from $231M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Claris Advisors deployed $40M of net new capital in Q4 2024, opening 2 new positions and adding to 60 existing holdings. Its largest new stake was Vanguard High Dividend Yield ETF: 4,900 shares worth $625K.

By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 1.9% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $98.5K trimmed.

  • Claris Advisors's largest Q4 2024 buy was Vanguard High Dividend Yield ETF: 4,900 shares worth $625K.
  • Claris Advisors added most to Dimensional US Core Equity 2 ETF in Q4 2024, an estimated $13.5M increase.
  • Claris Advisors's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $98.5K.
  • Claris Advisors fully exited Dimensional US Real Estate ETF in Q4 2024, selling an estimated $204K.
  • Claris Advisors's ten largest holdings make up 76% of its $266M portfolio in Q4 2024.
  • Claris Advisors opened 2 new positions and closed 1,166 in Q4 2024.
  • Claris Advisors's portfolio value rose 15% quarter-over-quarter to $266M.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.